Page last updated: 2024-11-06

tangeretin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tangeretin is a polymethoxylated flavone found in citrus fruits, particularly in the peels of tangerines and oranges. It exhibits a wide range of biological activities, including antioxidant, anti-inflammatory, anti-cancer, and neuroprotective effects. Its synthesis involves a complex series of enzymatic reactions within citrus plants. Researchers are studying tangeretin due to its potential therapeutic applications, particularly in the treatment of cancer, neurodegenerative diseases, and inflammatory conditions. Tangeretin has shown promising results in preclinical studies, inhibiting the growth of various cancer cell lines and protecting neurons from damage. However, further research is needed to fully understand its mechanisms of action and to assess its safety and efficacy in humans.'

tangeretin: structure given in first source; from citrus plants; inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tangeretin : A pentamethoxyflavone flavone with methoxy groups at positions 4', 5, 6 , 7 and 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

pentamethoxyflavone : A methoxyflavone that is flavone substituted by a five methoxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
CitrusgenusA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.[MeSH]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID68077
CHEMBL ID73930
CHEBI ID9400
SCHEMBL ID19740
MeSH IDM0164309

Synonyms (90)

Synonym
smr001557394
AC-1699
CHEMBL73930 ,
nsc618905
nsc-618905
flavone, 5,6,7,8,4'-pentamethoxy
nsc-53909
4h-1-benzopyran-4-one,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-
pentamethoxyflavone
ponkanetin
4h-1-benzopyran-4-one,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-
tangeritin
nsc53909
flavone,5,6,7,8-pentamethoxy-
mls002667634 ,
NCI60_004330
SDCCGMLS-0066766.P001
4',5,6,7,8-pentamethoxyflavone
5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one
5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4h-chromen-4-one
CHEBI:9400 ,
4h-1-benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-
einecs 207-570-1
4h-1-benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-
2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-4h-1-benzopyran-4-one
4h-1-benzopyran-4-one, 2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-
ai3-23869
5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4-benzopyrone
brn 0351695
nsc 53909
flavone, 4',5,6,7,8-pentamethoxy- (7ci,8ci)
ACON1_001263
MEGXP0_001011
tangeretin
5,6,7,8,4'-pentamethoxyflavone
481-53-8
4h-1-benzopyran-4-one, 5,6,7,8-tetra-methoxy-2-(4-methoxyphenyl)-
5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one
CU-01000013437-2
NCGC00095850-01
KBIO3_001900
KBIOGR_001517
SPBIO_001656
SPECTRUM2_001698
SPECTRUM4_001019
SPECTRUM3_000920
SPECTRUM1505269
NCGC00169520-01
BRD-K25186396-001-02-1
bdbm50209218
5,6,7,8,4''-pentamethoxyflavone
4'',5,6,7,8-pentamethoxyflavone
4',5,6,7,8-pentamethoxy-flavone
LMPK12111443
NCGC00095850-02
5-18-05-00491 (beilstein handbook reference)
i4tla1dlx6 ,
flavone, 4',5,6,7,8-pentamethoxy-
unii-i4tla1dlx6
A827490
T2708
CCG-38782
FT-0632194
AKOS015895209
S2363
tangeretin [who-dd]
tangeritin [inci]
SCHEMBL19740
Q-100525
mfcd00017438
HY-N0133
CS-5484
tangeretin (6ci)
tangeretin, analytical standard
DTXSID30197417 ,
HMS3651A22
sr-05000002625
SR-05000002625-1
tangeretin, >=95% (hplc)
5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one, 9ci
SW219232-1
tangeretin (tangeritin)
AS-11637
Q1748737
BRD-K25186396-001-04-7
tangeritin; nsc53909; nsc618905
tangeretin;tangeratin
5,6,7,8,4-pentamethoxyflavone
flavone, 4',5,6,7,8-pentamethoxy-(7ci,8ci)
dtxcid40119908

Research Excerpts

Overview

Tangeretin is an O-polymethoxylated flavone present in citrus peels. It exerts several beneficial effects, including anti-inflammation, anti-oxidation and neuroprotection. Tange retin has shown potent anti-cancer activity in different types of cancer cells.

ExcerptReferenceRelevance
"Tangeretin is a bioactive pentamethoxyflavone mainly found in citrus peels, and it has been reported to protect against hyperlipidemia, diabetes, and obesity."( The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Chao, TY; Chen, PY; Gao, WY; Hsu, HJ; Lin, CY; Wang, CY; Wu, MJ; Yen, JH, 2021
)
1.63
"Tangeretin is a polymethoxylated flavonoid naturally occurred in citrus fruits with many pharmacological activities, such as anti-inflammatory, antiproliferative, and neuroprotective properties. "( Tangeretin promotes lifespan associated with insulin/insulin-like growth factor-1 signaling pathway and heat resistance in Caenorhabditis elegans.
Fan, S; Huang, C; Liu, Y; Wang, F; Wang, H; Yin, L; Zhang, L; Zhou, Z; Zhu, H; Zhu, M, 2022
)
3.61
"Tangeretin is a natural compound having various pharmacological activities including antioxidation and hepatoprotection."( Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice.
Chen, R; Jiang, S; Ke, Z; Li, H; Li, M; Li, Y; Tan, S, 2022
)
2.89
"Tangeretin is a natural flavonoid abundantly present in orange peel and tangerines."( Influence of Tangeretin on the Exponential Regression of Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic Nephropathy.
Huang, R; Liu, F; Qin, Z; Sun, P, 2022
)
1.81
"Tangeretin is a citrus flavonoid that exerts several beneficial effects, including anti-inflammation, anti-oxidation and neuroprotection. "( Tangeretin mitigates l-NAME-induced ventricular dysfunction and remodeling through the AT
Bunbupha, S; Kukongviriyapan, U; Maneesai, P; Pakdeechote, P; Rattanakanokchai, S; Tong-Un, T; Wunpathe, C, 2020
)
3.44
"Tangeretin (TGN) is a key member of flavonoids that is extensively found in citrus peels."( Tangeretin: a mechanistic review of its pharmacological and therapeutic effects.
Ahmadi, Z; Ashrafizadeh, M; Ghasemipour Afshar, E; Mohammadinejad, R, 2020
)
2.72
"Tangeretin is a polymethoxylated flavone found extensively in citrus fruits and has shown potent anti-cancer activity in different types of cancer cells."( Prospects of tangeretin as a modulator of cancer targets/pathways.
Luqman, S; Meena, A; Raza, W, 2020
)
1.65
"Tangeretin is an O-polymethoxylated flavone present in citrus peels with anti-inflammatory and antioxidant properties."( Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia.
Kang, MK; Kang, YH; Kim, SI; Na, W; Oh, SY, 2020
)
2.72
"Tangeretin is a polymethoxylated flavone with multifaceted anticancer activity. "( Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
Androutsopoulos, VP; Arroo, RR; Surichan, S; Tsatsakis, AM, 2018
)
3.37
"Tangeretin is a plant-derived flavonoid that retains antidiabetic effects."( Tangeretin inhibits streptozotocin-induced cell apoptosis via regulating NF-κB pathway in INS-1 cells.
Han, J; Li, D; Liu, Y; Zhou, Z, 2019
)
2.68
"Tangeretin is a citrus flavonoid known to inhibit cancer cell proliferation."( Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.
Arafa, el-SA; Barakat, BM; El-Mahdy, MA; Wani, AA; Wani, G; Zhao, Q; Zhu, Q, 2009
)
2.52
"Tangeretin is a methoxyflavone from citrus fruits, which inhibits growth of human mammary cancer cells and cytolysis by natural killer cells. "( Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation.
Boterberg, T; Bracke, ME; Coopman, P; De Bondt, B; Depypere, HT; Foré, F; Leclercq, G; Parmar, VS; Sharma, SK; Van Slambrouck, S; Vanhoecke, BW, 2005
)
3.21
"Tangeretin is a flavonoid that stimulates the catalytic activity of cytochrome P450 3A4 (CYP3A4) and is found in high levels in tangerine juice."( Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
Backman, JT; Belle, DJ; Kivistö, KT; Mäenpää, J; Neuvonen, PJ; Wrighton, SA, 2000
)
1.98
"Tangeretin is a potent regioselective stimulator of midazolam 1'-hydroxylation by human liver microsomes and complementary deoxyribonucleic acid-expressed CYP3A4. "( Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
Backman, JT; Belle, DJ; Kivistö, KT; Mäenpää, J; Neuvonen, PJ; Wrighton, SA, 2000
)
1.98

Actions

Tangeretin was found to inhibit phosphoinositide 3-kinase-mediated signaling and increase cGMP levels in platelets, although phosphodiesterase activity was unaffected. The drug did not enhance its own metabolism.

ExcerptReferenceRelevance
"Tangeretin reduced the increase of apoptosis ratio and revered the altered expressions of Bax and Bcl-2 caused by STZ induction."( Tangeretin inhibits streptozotocin-induced cell apoptosis via regulating NF-κB pathway in INS-1 cells.
Han, J; Li, D; Liu, Y; Zhou, Z, 2019
)
2.68
"Tangeretin was found to inhibit phosphoinositide 3-kinase-mediated signaling and increase cGMP levels in platelets, although phosphodiesterase activity was unaffected."( Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Ali, MS; Gibbins, JM; Jones, CI; Lewis, KR; Moraes, LA; Sage, T; Vaiyapuri, S, 2013
)
2.55
"Tangeretin did not enhance its own metabolism."( Evidence for tangeretin O-demethylation by rat and human liver microsomes.
Brunold, C; Canivenc-Lavier, MC; Siess, MH; Suschetet, M, 1993
)
1.38

Treatment

Tangeretin treatment reduced inflammatory cell infiltration in bronchoalveolar lavage fluid (BALF) and restored the normal histology of lung tissues. No significant changes were observed in the levels of antioxidants and breast cancer marker.

ExcerptReferenceRelevance
"Tangeretin treatment of hepatic cells also reduced the levels of both intracellular and secreted ANGPTL3 proteins."( The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Chao, TY; Chen, PY; Gao, WY; Hsu, HJ; Lin, CY; Wang, CY; Wu, MJ; Yen, JH, 2021
)
1.63
"Tangeretin treatment dose-dependently suppressed the MEK-ERK1/2 pathway, while forced activation of p-ERK1/2 reversed the insulin sensitized effect of tangeretin."( Citrus flavone tangeretin is a potential insulin sensitizer targeting hepatocytes through suppressing MEK-ERK1/2 pathway.
Chen, J; Guo, J; Li, K; Qiu, C; Ren, W; Su, D; Zhang, K; Zhang, W; Zhao, Q; Zhu, Y, 2020
)
1.63
"Tangeretin treatment significantly attenuated the memory deficits and improved motor functions and cognition."( Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats.
Teng, LS; Wu, XH; Yang, JS; Yu, HG, 2017
)
2.62
"Tangeretin treatment reduced inflammatory cell infiltration in bronchoalveolar lavage fluid (BALF) and also restored the normal histology of lung tissues."( Tangeretin has anti-asthmatic effects via regulating PI3K and Notch signaling and modulating Th1/Th2/Th17 cytokine balance in neonatal asthmatic mice.
Li, FH; Liu, LL; Yang, J; Zhang, XF; Zhang, Y, 2017
)
2.62
"Tangeretin treatment revealed a significant decline in the levels of lipid peroxides, inflammatory cytokines and markers of DNA damage, and a significant improvement in the levels of enzymatic and non-enzymatic antioxidants in the kidney tissue."( Tangeretin ameliorates oxidative stress in the renal tissues of rats with experimental breast cancer induced by 7,12-dimethylbenz[a]anthracene.
Lakshmi, A; Subramanian, SP, 2014
)
2.57
"Oral tangeretin treatment also effectively reduced the tumor cell proliferation markers such as PCNA, COX-2 and Ki-67."( Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinoma.
Arivazhagan, L; Sorimuthu Pillai, S, 2014
)
2.3
"In tangeretin alone treated Group V animals, no significant changes were observed in the levels of antioxidants and breast cancer marker."( Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats.
Baskaran, K; Ilakkia, A; Periyasamy, K; Sakthisekaran, D; Selvaraj, S; Vanitha, K, 2015
)
1.25
"Tangeretin pre-treatment significantly improved liver function tests (ALT and AST), inhibited cisplatin-induced lipid profile aberrations (total cholesterol and triglycerides) and diminished histopathologic structural damage in liver tissues."( Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis.
Arab, HH; Arafa, el-SA; Mohamed, WR; Omar, HA, 2016
)
2.6
"Tangeretin treatment produced changes similar to flavone but of lesser magnitude and after a longer delay."( Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids.
Canivenc-Lavier, MC; Mas, JP; Siess, MH; Suschetet, M, 1996
)
1.02
"Co-treatment with Tangeretin was effective in alleviating Tunicamycin-induced ER stress and associated redox-related complications by significantly downregulating the unfolded protein response (UPR), ER resident oxidoreductase proteins, cellular ROS and improving the antioxidant enzyme activity."( Tangeretin alleviates Tunicamycin-induced endoplasmic reticulum stress and associated complications in skeletal muscle cells.
Anto, EM; Krishnan, L; Purushothaman, J; Raghu, KG; Sruthi, CR, 2023
)
2.68
"Oral treatment of tangeretin (50 mg/kg BW) to breast tumor bearing rats daily for four weeks was found to be effective against DMBA induced mammary gland carcinogenesis in female Wistar rats."( Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats.
Lakshmi, A; Subramanian, S, 2014
)
1.02
"Treatment with tangeretin-induced cell-cycle arrest in the G₀/G₁ phase was associated with down-regulation of cyclin D1 and cyclin E in addition to up-regulation of p27(kip1)."( Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
Lee, HS; Lee, JH; Min, BS; Ryoo, S; Seo, J; Seo, JH, 2011
)
2.15
"Treatment with tangeretin did not inhibit tumor growth, and addition of this compound to drinking water with tamoxifen completely neutralized tamoxifen's inhibitory effect."( Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.
Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Van Marck, VL; Vanluchene, E; Vennekens, KM, 1999
)
1.01

Toxicity

ExcerptReferenceRelevance
" No other adverse effects were observed in the 90-day study."( An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar 'Ohta ponkan' (Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity.
Nakajima, A; Nemoto, K; Ohizumi, Y, 2020
)
0.75

Pharmacokinetics

Pharmacokinetic behaviors of silybin in rats were altered by co-administration of tangeretin. This study aimed to investigate the pharmacokinetic interactions among atorvastatin, its active metabolite 2-hydroxy ator Vastatin and tange Retin.

ExcerptReferenceRelevance
" The half-life of each of these compounds in the silkworm hemolymph was 18, 26 and 34 h, respectively."( Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources.
Asami, Y; Hamamoto, H; Horie, R; Sekimizu, K, 2010
)
0.36
"These findings suggest that silkworms can be used as a model animal to easily identify compounds with appropriate pharmacokinetic behavior."( Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources.
Asami, Y; Hamamoto, H; Horie, R; Sekimizu, K, 2010
)
0.36
" Pharmacokinetic behaviors of silybin in rats were altered by co-administration of tangeretin, in terms of increased AUC and Cmax of silybin by comparing with that of silybin given alone."( Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies.
Feng, SL; Li, YZ; Liu, CX; Liu, L; Liu, ZQ; Xie, Y; Yuan, ZW; Zhou, H, 2018
)
1.14
" This study aimed to investigate the pharmacokinetic interactions among atorvastatin, its active metabolite 2-hydroxy atorvastatin, and tangeretin after oral administration of atorvastatin with tangeretin in rats."( Ultra-high performance supercritical fluid chromatography-tandem mass spectrometry method for simultaneous determination of atorvastatin, 2-hydroxy atorvastatin, and tangeretin in rat plasma and its application to the pharmacokinetic study.
Gong, L; Jiang, Q; Li, W; Li, Y; Ni, D; Wang, S; Wang, W; Wu, W; Xu, X; Zhang, J; Zhang, T; Zhang, Y, 2022
)
1.12

Compound-Compound Interactions

ExcerptReferenceRelevance
"The present study aimed to develop a strategy involving quantitative analysis of multicomponents by single marker in combination with high-performance liquid chromatography fingerprint qualitative analysis for performing the quality control of Aurantii Fructus."( Quantitative analysis of multicomponents by single marker combined with HPLC fingerprint qualitative analyses for comprehensive evaluation of Aurantii Fructus.
Cai, X; Huang, D; Lei, Y; Lin, M; Luo, K; Sun, Z; Tan, S; Wang, Y; Xia, X; Yan, J; Zhang, Y, 2020
)
0.56

Bioavailability

The oral bioavailability of tangeretin, a poly(methoxyflavone) found in citrus fruits, is typically very low because of its extremely limited solubility. To improve bioavailability and increase potency, its derivative, 5-AcTMF, has been synthesized and shown potent inhibition of proliferation activity against human breast and leukemia cancer cell lines.

ExcerptReferenceRelevance
" They may have potential as agents for reversing multidrug resistance or for recovering the bioavailability of certain drugs."( Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
Matsuo, H; Morimoto, S; Ohnishi, A; Ohtani, H; Sawada, Y; Shoyama, Y; Takanaga, H; Yamada, S, 2000
)
0.31
"Neuroprotective effects of a natural antioxidant tangeretin, a citrus flavonoid, were elucidated in the 6-hydroxydopamine (6-OHDA) lesion rat model of Parkinson's disease (PD), after bioavailability studies."( Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease.
Christidou, M; Datla, KP; Dexter, DT; Rooprai, HK; Widmer, WW, 2001
)
0.8
" In conclusion, various beverages, especially teas, inhibit the function of SULT1A3, and therefore may have the potential to increase the bioavailability of orally administered substrates of SULT1A3, such as beta(2) agonists."( Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
Hiratsuka, A; Nishimuta, H; Ogura, K; Ohtani, H; Sawada, Y; Tsujimoto, M, 2007
)
0.34
" Although the impacts of NOB and TAN on glucose homeostasis and cholesterol regulation have been investigated in human clinical trials, much information is still lacking about the metabolism and oral bioavailability of these compounds in animals."( Pharmacokinetic study of nobiletin and tangeretin in rat serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry.
Cesar, TB; Jackson, E; Manthey, JA; Mertens-Talcott, S, 2011
)
0.64
"The oral bioavailability of hydrophobic compound is usually limited by the poor aqueous solubility in the gastrointestinal (GI) tract."( Viscoelastic Emulsion Improved the Bioaccessibility and Oral Bioavailability of Crystalline Compound: A Mechanistic Study Using in Vitro and in Vivo Models.
Huang, Q; Jiang, Y; Lan, Y; Lin, Z; Rogers, MA; Ting, Y; Xia, C, 2015
)
0.42
" To improve bioavailability and increase potency of tangeretin, its derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone (5-AcTMF), has been synthesized and shown potent inhibition of proliferation activity against human breast and leukemia cancer cell lines."( Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo.
Chang, YH; Chen, YK; Chung, TW; Ho, CT; Li, S; Li, YR; Lin, CC; Tan, KT; Wang, BY, 2016
)
2.13
" However, low bioavailability seriously limits wide-application of SB in biomedical niche."( Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism.
Chen, SY; Pang, XC; Suguro, R; Xie, Y; Yuan, ZW; Zhu, YZ, 2020
)
0.83
"The oral bioavailability of tangeretin, a poly(methoxyflavone) found in citrus fruits, is typically very low because of its extremely limited solubility."( Biopolymer Additives Enhance Tangeretin Bioavailability in Emulsion-Based Delivery Systems: An
Hu, Y; Li, B; Li, Y; Liu, F; McClements, DJ; Pang, J; Zhou, Z, 2021
)
1.21

Dosage Studied

ExcerptRelevanceReference
" To enhance the oral dosing efficiency of polymethoxyflavone, a viscoelastic emulsion system with a high static viscosity was developed and optimized using tangeretin, one of the most abundant polymethoxyflavones found in natural sources, as a modeling compound."( Viscoelastic Emulsion Improved the Bioaccessibility and Oral Bioavailability of Crystalline Compound: A Mechanistic Study Using in Vitro and in Vivo Models.
Huang, Q; Jiang, Y; Lan, Y; Lin, Z; Rogers, MA; Ting, Y; Xia, C, 2015
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
pentamethoxyflavoneA methoxyflavone that is flavone substituted by a five methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (29)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
USP1 protein, partialHomo sapiens (human)Potency89.12510.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency18.66170.000811.382244.6684AID686978; AID686979
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency1.41250.011212.4002100.0000AID1030
chromobox protein homolog 1Homo sapiens (human)Potency63.09570.006026.168889.1251AID540317
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00060.010039.53711,122.0200AID1479
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
TAR DNA-binding protein 43Homo sapiens (human)Potency3.98111.778316.208135.4813AID652104
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency31.62283.981146.7448112.2020AID720708
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)39.00000.00022.318510.0000AID578762
Urease subunit alphaHelicobacter pylori 26695IC50 (µMol)4,628.00000.29003.87606.7000AID745311
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)100.00000.00132.81389.8200AID399340
Urease subunit betaHelicobacter pylori 26695IC50 (µMol)4,628.00000.29003.87606.7000AID745311
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)IC50 (µMol)18.00000.00401.966610.0000AID578759; AID578760
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (78)

Processvia Protein(s)Taxonomy
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (42)

Processvia Protein(s)Taxonomy
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (24)

Processvia Protein(s)Taxonomy
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (97)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID696740Inhibition of p-glycoprotein in human LoVo/DX cells assessed nuclear accumulation of doxorubicin at 100 uM after 60 mins by fluorescence assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID1190338Displacement of [3H]DAMGO from mu opioid receptor in CD1 mouse whole brain minus cerebellum membranes by liquid scintillation counting2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies.
AID356482Antihistaminic activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced beta-hexosaminidase release preincubated for 10 mins before DNP-BSA challenge2003Journal of natural products, Sep, Volume: 66, Issue:9
Tricin from a malagasy connaraceous plant with potent antihistaminic activity.
AID696737Potentiation of doxorubicin-induced cytotoxicity in human LoVo cells at 5 uM after 72 hrs by SRB assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696722Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as necrotic cells at 100 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 9.57 +/- 2.83%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696715Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as activation of caspase-3 at 75 uM after 48 hrs relative to control2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID1100871Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves by Choice Leaf-Disk Bioassay2000Journal of agricultural and food chemistry, May, Volume: 48, Issue:5
Insect antifeedant flavonoids from Gnaphalium affine D. Don.
AID1102050Antifeedant activity against Spodoptera litura F. by choice leaf disk assay2003Journal of agricultural and food chemistry, Jan-15, Volume: 51, Issue:2
Insect antifeedant activity of flavones and chromones against Spodoptera litura.
AID515157Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
AID578759Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID404069In vivo antitumor activity against mouse L1210 cells
AID379054Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID404070In vivo antitumor activity against mouse CA-755 cells
AID697156Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as activation of caspase-3 at 100 uM after 48 hrs relative to control2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696729Induction of apoptosis in human drug-sensitive LoVo cells assessed as necrotic cells at 25 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 10.44 +/- 3.23%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID404067In vivo antitumor activity against mouse S180 cells
AID404015In vivo antitumor activity against hamster P1 cells
AID404014In vivo antitumor activity against hamster PX cells
AID680095TP_TRANSPORTER: increase in saquinavir intracellular accumulation of Tangeretin at a concentration of 20uM in LLC-GA5-COL150 cells2004British journal of pharmacology, Dec, Volume: 143, Issue:7
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
AID411503Anticancer activity against human HT-29 cells after 72 hrs by MTT assay2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
AID696746Cytotoxicity against human drug-sensitive LoVo cells after 72 hrs by SRB assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID681339TP_TRANSPORTER: inhibition of Estrone-3-sulfate uptake (Estrone-3-sulfate: 10nM) in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID578760Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID696730Induction of apoptosis in human drug-sensitive LoVo cells assessed as necrotic cells at 100 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 10.44 +/- 3.23%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696745Cytotoxicity against human drug-resistant LoVo/DX cells after 72 hrs by SRB assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID144650In vitro cytotoxic potency against NCI-60 human tumor cell line1998Journal of medicinal chemistry, Jun-18, Volume: 41, Issue:13
Structure-activity requirements for flavone cytotoxicity and binding to tubulin.
AID696721Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as necrotic cells at 25 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 9.57 +/- 2.83%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID578761Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID635947Inhibition of PMA-stimulated pro MMP9 production in human SRA 01/04 cells after 24 hrs by SDS-PAGE based gelatin zymography assay2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production.
AID288088Cytotoxicity against human PMN cells at 100 uM2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines.
AID578762Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID696716Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as activation of caspase-3 at 25 uM after 48 hrs relative to control2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID310882Inhibition of HIV1 replication2007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
Simple criterion for selection of flavonoid compounds with anti-HIV activity.
AID1101843Induction of resistance against Phytophthora citrophthora in Citrus (tangelo Nova) fruits assessed as increase of polymethoxyflavones levels at 20 to 250 ppm after 7 days2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID696743Inhibition of doxorubicin intracellular accumulation in human LoVo cells at 100 uM after 60 mins by fluorescence assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID578844Cytotoxicity against human MCF7 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID1190339Displacement of [3H]DPDPE from delta opioid receptor in CD1 mouse whole brain minus cerebellum membranes by liquid scintillation counting2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies.
AID696720Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as necrotic cells at 75 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 9.57 +/- 2.83%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696719Induction of apoptosis in human drug-sensitive LoVo cells assessed as activation of caspase-3 at 75 uM after 48 hrs relative to control2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID399341Antioxidant activity assessed as superoxide-scavenging activity by nitrite method1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID680688TP_TRANSPORTER: increase in Vinblastine intracellular accumulation of Tangeretin at a concentration of 20uM in LLC-GA5-COL150 cells2004British journal of pharmacology, Dec, Volume: 143, Issue:7
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
AID578765Inhibition of P-gp expressed in A2780adr cells at 10 uM by calcein AM accumulation assay relative to verapamil2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID635945Inhibition of TNFalpha-stimulated pro MMP9 production in human SRA 01/04 cells after 24 hrs by SDS-PAGE based gelatin zymography assay2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production.
AID696733Induction of apoptosis in human drug-sensitive LoVo cells assessed as apoptotic cells at 25 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 6.68 +/- 1.77%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696726Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as apoptotic cells at 100 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 6.16 +/- 1.67%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID635946Cytotoxicity against human SRA 01/04 cells at 64 uM after 24 hrs by LDH release assay2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production.
AID356483Cytotoxicity against rat RBL2H3 cells at 500 uM by optical microscope2003Journal of natural products, Sep, Volume: 66, Issue:9
Tricin from a malagasy connaraceous plant with potent antihistaminic activity.
AID745311Inhibition of Helicobacter pylori ATCC 43504 urease-mediated ammonia production preincubated for 1.5 hrs by indophenol method2013European journal of medicinal chemistry, May, Volume: 63Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
AID696736Inhibition of p-glycoprotein in human LoVo/DX cells assessed as potentiation of doxorubicin-induced cytotoxicity at 5 uM after 72 hrs by SRB assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID680683TP_TRANSPORTER: increase in Vinblastine uptake (Vinblastine: 0.02 uM, Tangeretin: 20 uM) in MDR1-expressing LLC-PK1 cells2000The Journal of pharmacology and experimental therapeutics, Apr, Volume: 293, Issue:1
Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
AID696728Induction of apoptosis in human drug-sensitive LoVo cells assessed as necrotic cells at 75 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 10.44 +/- 3.23%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696718Induction of apoptosis in human drug-sensitive LoVo cells assessed as activation of caspase-3 at 100 uM after 48 hrs relative to control2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID288087Apoptotic activity in HL60 cells after 24 hrs2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1101842Induction of resistance against Phytophthora citrophthora in Citrus (tangelo Nova) fruits assessed as increase of polymethoxyflavones levels at 20 to 250 ppm up to 160 days2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID288086Antiproliferative activity against HL60 after 24 hrs2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines.
AID1190340Selectivity ratio of Ki for delta opioid receptor in CD1 mouse whole brain minus cerebellum membranes to Ki for mu opioid receptor in CD1 mouse whole brain minus cerebellum membranes2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies.
AID696724Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as apoptotic cells at 75 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 6.16 +/- 1.67%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID334635Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID404008Cytotoxicity against human KB cells
AID330892Growth inhibition of human SHSY5Y cells assessed as viable cells after 48 hrs by Trypan blue dye exclusion test2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
AID411504Anticorpulence activity against mouse 3T3L1 cells assessed as inhibition of lipid droplet accumulation2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
AID1101844Antifungal activity against Penicillium digitatum2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID696741Inhibition of p-glycoprotein in human LoVo/DX cells assessed accumulation of rhodamine 123 at 75 to 100 uM after 60 mins by fluorescence assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID724431Growth inhibition of human SRA 01/04 cells at 32 uM after 4 days by Alamar blue assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Polymethoxyflavones as agents that prevent formation of cataract: nobiletin congeners show potent growth inhibitory effects in human lens epithelial cells.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID681338TP_TRANSPORTER: inhibition of glibenclamide uptake (glibenclamide: 10nM) in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID696732Induction of apoptosis in human drug-sensitive LoVo cells assessed as apoptotic cells at 75 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 6.68 +/- 1.77%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID371771Cytotoxicity against human KB cells at 1 uM after 72 hrs by MTS assay2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones.
AID334634Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID371774Induction of apoptosis in human HL60 cells assessed as caspase 3/7 activation at 100 uM relative to control2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones.
AID696742Inhibition of rhodamine 123 accumulation in human LoVo cells at 75 to 100 uM after 60 mins by fluorescence assay2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID399340Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID696734Induction of apoptosis in human drug-sensitive LoVo cells assessed as apoptotic cells at 100 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 6.68 +/- 1.77%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696725Induction of apoptosis in human drug-sensitive LoVo/DX cells assessed as apoptotic cells at 25 uM after 48 hrs by annexin-V and propidium iodide staining based flow cytometry (Rvb = 6.16 +/- 1.67%)2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID696739Induction of apoptosis in human drug-sensitive LoVo cells assessed as activation of caspase-3 at 25 uM after 48 hrs relative to control2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
AID1101848Antifungal activity against Phytophthora citrophthora after 100 hr2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID1101845Antifungal activity against Phytophthora citrophthora assessed as inhibition of radical growth at 0.1 to 1 g/L up to 200 hr2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID1603991Growth inhibition of human HL60 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Nov-01, Volume: 181The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile.
AID578843Cytotoxicity against human A2780 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (236)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (0.85)18.7374
1990's24 (10.17)18.2507
2000's47 (19.92)29.6817
2010's109 (46.19)24.3611
2020's54 (22.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.16 (24.57)
Research Supply Index5.51 (2.92)
Research Growth Index5.92 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.82%)5.53%
Reviews13 (5.33%)6.00%
Case Studies1 (0.41%)4.05%
Observational0 (0.00%)0.25%
Other228 (93.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]